Evidence map›Paper›PMID 37868192›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2023

The Platelet Anaphylatoxin Receptor C5aR1 (CD88) Is a Promising Target for Modulating Vessel Growth in Response to Ischemia

Henry Nording, Lasse Baron, Antje Lübken, Hossein Emami, Jacob von Esebeck, Moritz Meusel, Christian Sadik, Nancy Schanze, Daniel Duerschmied, Jörg Köhl and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Henry NordingCardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.
Lasse BaronCardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.
Antje LübkenCardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.
Hossein EmamiCardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.
Jacob von EsebeckCardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.
Moritz MeuselMedical Clinic II, University Hospital, University Heart Center Lübeck, Lübeck, Germany.
Christian SadikClinic for Dermatology, University of Lübeck, University Hospital, Lübeck, Germany.
Nancy SchanzeDepartment of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Daniel DuerschmiedDepartment of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Jörg KöhlISEF, University of Lübeck, Lübeck, Germany.
Götz MünchAdvanceCOR, Martinsried, Germany.
Harald F LangerCardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.
University of Lübeck · DEGerman Centre for Cardiovascular Research · DEadvanceCOR (Germany) · DEHeidelberg University · DEUniversity Medical Centre Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37868192
PMCPMC10586890
OpenAlexW4385971003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.